MOTS-c UK: The MOTS-c Peptide Guide (2026)

MOTS-c for UK researchers: the mitochondrial-derived peptide, its 2015 discovery, AMPK and exercise research, the human data gap and 2026 legal status.

5 min readUpdated 15 Oct 2026

Summary of published research for laboratory reference. Products are not for human consumption.

By the SARMs Store editorial team, reviewed by the SARMs Store research team. Products on this site are supplied strictly for laboratory research and are not for human consumption. This guide summarises published research; it is not medical advice and contains no instructions for use. 18+ only.

MOTS-c at a glance

Class Mitochondrial-derived peptide, 16 amino acids (MRWQEMGYIFYPRKLR)
Discovered by Lee and colleagues, University of Southern California, 2015
Highest evidence Cell and rodent studies; human observational studies of natural levels
Studied for Mitochondrial to nuclear signalling, AMPK, glucose handling, ageing and physical capacity in mice
CAS number 1627580-64-6
Format Lyophilised powder in a sealed vial
UK status 2026 Research chemical; not licensed anywhere; WADA S4.4 metabolic modulator
Origin Peptides MOTS-c 10mg Vial
Research this compound
10 mg · vial.

What MOTS-c is

Almost all of the proteins in a cell are encoded by DNA in the nucleus. Mitochondria keep a small genome of their own, and in the last two decades researchers have found short sequences within it that produce signalling peptides. MOTS-c, encoded within the 12S rRNA gene, is the best studied of these mitochondrial-derived peptides, alongside humanin. It matters to researchers because it suggests mitochondria do not only respond to signals from the rest of the cell but also send their own.

MOTS-c peptide UK: what buyers should know

MOTS-c is one of the fastest-growing peptide searches in the UK, usually written as MOTS-c, MOTS c or MOT-c. It is the best known of the mitochondrial-derived peptides, a family discovered in the last decade, and most interest comes from the mouse studies on exercise capacity and metabolism. Our Origin Peptides MOTS-c 10mg is a sealed, batch-numbered lyophilised vial dispatched from our UK warehouse at £49.99.

MOTS-c compared with the other longevity peptides

Compound What it is Main research area In our range
MOTS-c 16 amino acid mitochondrial-derived peptide AMPK, glucose handling, exercise capacity in mice MOTS-c 10mg
SS-31 Tetrapeptide that targets the mitochondrial membrane Mitochondrial function, cardiolipin SS-31 10mg
NAD+ Coenzyme (not a peptide) Cellular energy, sirtuins, ageing NAD+
5-Amino-1MQ Small molecule NNMT inhibitor Fat cell metabolism in mice 5-Amino-1MQ 10mg
Epithalon Tetrapeptide Telomerase, ageing Epithalon 10mg

MOTS-c and SS-31 are the two compounds in this group that act on the mitochondria directly, which is why they are the pair most often compared.

What to check before buying MOTS-c

  1. Milligrams per vial: 5mg, 10mg and 40mg are all sold; compare price per mg.
  2. The full 16 amino acid sequence, MRWQEMGYIFYPRKLR, and CAS 1627580-64-6 on the certificate.
  3. HPLC purity and mass spectrometry identity matching a molecular weight of about 2,175 g/mol.
  4. UK stock and tracked UK delivery.

Every Origin Peptides batch is independently tested and its certificate of analysis is published on the product page and the Lab Testing page.

What the research found

Discovery. Lee and colleagues reported in Cell Metabolism in 2015 that MOTS-c acted on the folate cycle and de novo purine synthesis, leading to activation of AMPK, and that in mice on a high fat diet it was associated with better insulin sensitivity and less weight gain. Skeletal muscle appeared to be its main target tissue.

Nuclear signalling. Kim and colleagues reported in Cell Metabolism in 2018 that under metabolic stress MOTS-c moves into the nucleus and influences the expression of genes involved in the antioxidant response, an unusual route for a mitochondrially encoded peptide.

Exercise and ageing. Reynolds and colleagues reported in Nature Communications in 2021 that MOTS-c levels in human blood and skeletal muscle rose with exercise, and that treating old mice was associated with improved physical capacity. Other groups have reported that circulating levels differ with age and metabolic state, though the findings are not always consistent.

Clinical development. CohBar developed an analogue, CB4211, which entered early phase clinical testing in people with fatty liver disease and obesity. It has not progressed to approval and no data on MOTS-c itself given to humans have been published in a controlled trial.

What is missing. Controlled human trials of MOTS-c, pharmacokinetic data in humans, and independent replication of several of the rodent findings.

Stability, storage and handling

Lyophilised MOTS-c is stable in transit. Sealed vials should be refrigerated at 2 to 8C, protected from light, or kept at -20C for longer storage. The peptide contains two methionine residues, which are prone to oxidation, so vials should stay sealed until use. The certificate should show HPLC purity and a mass spectrometry identity consistent with a molecular weight of about 2,175 g/mol.

Legal status in the UK, 2026

Not a controlled substance under the Misuse of Drugs Act 1971. MOTS-c is not a licensed medicine anywhere, so it cannot be sold or advertised for human use in the UK and is supplied strictly for laboratory research. The WADA Prohibited List names MOTS-c under section S4.4.1, metabolic modulators that activate AMPK, so it is prohibited at all times in sport.

Frequently asked questions

What does MOTS-c stand for?

Mitochondrial open reading frame of the 12S rRNA type-c. The name describes where in the mitochondrial genome the peptide is encoded.

Is MOTS-c a licensed medicine?

No. It has no licence anywhere. An analogue, CB4211, entered early clinical testing but has not been approved.

How is MOTS-c different from SS-31?

MOTS-c is produced by the mitochondria and signals outwards to the cell and nucleus. SS-31 (elamipretide) is a synthetic peptide that travels into the mitochondria and binds cardiolipin in the inner membrane.

Has MOTS-c been tested in humans?

Human studies so far mostly measure natural MOTS-c levels in blood and muscle. There are no published controlled trials of giving MOTS-c itself to people.

Is MOTS-c legal in the UK?

Legal to buy and possess as a research compound; not lawful to sell or advertise for human use. WADA names it under section S4.4.1 as a metabolic modulator, so it is prohibited at all times in sport.

Can you buy MOTS-c in the UK?

Yes, as a research peptide. Our MOTS-c 10mg vial is stocked and dispatched from the UK.

Are MOTS-c and MOT-c the same?

Yes. MOT-c and MOTS c are common spellings of MOTS-c.

Sources

  • Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015;21(3):443-454. PubMed 25738459
  • Kim KH, Son JM, Benayoun BA, Lee C. The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress. Cell Metabolism. 2018;28(3):516-524. PubMed 29983246
  • Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications. 2021;12:470. PubMed 33473109

Related guides

Research products: Origin Peptides MOTS-c 10mg · Full Origin Peptides range · Lab Testing

Origin Peptides MOTS-c 10mg Vial
Research this compound
10 mg · vial.
This guide summarises published research and is for laboratory reference only. Products are not for human consumption.
All guides